Vantage Reports
Drawing on Evaluate data, Vantage reports provide an in-depth view on trends in the biotech, pharma and medtech sectors. Our special reports also provide a detailed look at some of the industry's hottest topics.
Covid Round Up (2021)
The biopharma and medtech sectors have been racing to deliver treatments, vaccines and other solutions to Covid-19 for close to two years now. What progress has been made…
Covid Round Up (2021)
The biopharma and medtech sectors have been racing to deliver treatments, vaccines and other solutions to Covid-19 for close to two years now. What progress has been made…
European Society of Medical Oncology Conference (ESMO) 2021 （英語版）
Conducted as a virtual event from 16 to 21 September, ESMO 2021 brought together an international community of experts across disciplines. Once again, this oncology…
European Society of Medical Oncology Conference (ESMO) 2021
Conducted as a virtual event from 16 to 21 September, ESMO 2021 brought together an international community of experts across disciplines. Once again, this oncology…
2021 IASLC World Conference on Lung Cancer （英語版）
The year-end oncology congress season kicked off with the annual IASLC World Conference on Lung Cancer. While it took place in virtual format from September 8-14, this…
2021 IASLC World Conference on Lung Cancer
The year-end oncology congress season kicked off with the annual IASLC World Conference on Lung Cancer. While it took place in virtual format from September 8-14, this…
Evaluate Vantage SPAC article pack Sept 2021
Special purpose acquisition companies, known as Spacs or “blank check companies”, are not new but have recently rocketed in popularity as a vehicle for going public…
Evaluate Vantage SPAC article pack Sept 2021 （英語版）
Special purpose acquisition companies, known as Spacs or “blank check companies”, are not new but have recently rocketed in popularity as a vehicle for going public…
Biopharma and Medtech Half-Year Review 2021
Despite the continuing pandemic, the biopharma sector saw a return to relative stability during the first half of 2021. Remote operations are proving effective, deals are…
Evaluate Vantage Biopharma and Venture Capital: A Deep Dive
The sheer amount of private capital available to young drug developers the last few years is nothing new, however the Covid-19 pandemic has brought about an unprecedented…
